Evidence map›Paper›PMID 37198199›Full record

ArticleScientific reports2023

AZAR eye and vision cohort study.

Mohammad Hossein Somi, Zeinab Nikniaz, Alireza Ostadrahimi, Seyed Sina Naghibi Irvani, Amir Mohammad Nourizadeh, Mohammad Mirzaei, Fateme Alipour, Fatemeh Jafari, Elnaz Faramarzi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mohammad Hossein SomiLiver and Gastrointestinal Diseases Research Center of Tabriz University of Medical Sciences, P.O. Box: 1567812907, Tabriz, Iran.
Zeinab NikniazLiver and Gastrointestinal Diseases Research Center of Tabriz University of Medical Sciences, P.O. Box: 1567812907, Tabriz, Iran.
Alireza OstadrahimiNutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Seyed Sina Naghibi IrvaniLiver and Gastrointestinal Diseases Research Center of Tabriz University of Medical Sciences, P.O. Box: 1567812907, Tabriz, Iran. Sina.Irvani@sbmu.ac.ir.
Amir Mohammad NourizadehLiver and Gastrointestinal Diseases Research Center of Tabriz University of Medical Sciences, P.O. Box: 1567812907, Tabriz, Iran.
Mohammad MirzaeiDepartment of Ophthalmology, Tabriz University of Medical Sciences, Tabriz, Iran.
Fateme AlipourTranslational Ophthalmology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Fatemeh JafariTranslational Ophthalmology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Elnaz FaramarziLiver and Gastrointestinal Diseases Research Center of Tabriz University of Medical Sciences, P.O. Box: 1567812907, Tabriz, Iran. Faramarzie@tbzmed.ac.ir.
Tabriz University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

According to World Health Organization (WHO), currently, 2.2 billion people are living with visual impairment worldwide, of which almost half could have been prevented. There are both modifiable and unmodifiable factors leading to visual disability and, ultimately, blindness. Several population-based studies in different parts of Iran have tried to determine these factors concerning their specific population and environment-related characteristics. AZAR Eye and Vision cohort is the second-largest cohort study in the whole country. AZAR Eye and Vision cohort is the ophthalmologic branch of AZAR cohort which is the largest eye cohort study in the country, which is trying to determine the prevalence and incidence of visual impairment, blindness, and other major ophthalmologic conditions and their associated risk factors in East Azerbaijan province located in Iran, a middle eastern country. A recently emerging phenomenon is the drying of the ultra-salty lake of Urmia located in the West Azerbaijan province which is a direct neighbor of our studied population and has caused recurrent salt storms in the immediate near areas. This phenomenon could adversely affect visual health via different conditions which our study will elucidate. The enrollment phase took place between 2014 and 2017 and 11,208 participants were enrolled out of 15,000 participants in the primary cohort. The resurvey phase will begin five years after the enrollment phase. In this phase, 30% of the participants are randomly selected to be reexamined and complete questionnaires. The participants showing any issues such as diabetes and being a glaucoma suspect will be included in the resurvey phase, too. Data categories gathered include demographics, lifestyle factors, past medical and drug histories, and a diet quality and quantity questionnaire including 130 edible items. Urine, hair, nail, and 25-ml blood samples, were collected from the participants. Then they were referred to an optometrist to complete an ophthalmologic questionnaire and undergo eye examination and lensometry. Then they underwent slit-lamp examinations and pictures were taken of the lens and fundus. People with suspected visual impairment were referred to an ophthalmology clinic. The data are processed and a four-level quality check is performed on each block. The most common visual impairment is cataracts. This study's most important aim is to evaluate the effect of local environmental and ethnic factors on eye diseases in this specific population.

Indexed as

Eye DiseasesOcular HypertensionPersons with Visual DisabilitiesVision, LowBlindnessCohort StudiesHumansPrevalenceVision DisordersVisual Acuity

Identifiers

PMID37198199
PMCPMC10189707
OpenAlexW4377011430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.